Wall Street brokerages expect Limoneira (NASDAQ:LMNR) to post earnings per share of ($0.11) for the current quarter, Zacks Investment Research reports. Two analysts have made estimates for Limoneira’s earnings, with the lowest EPS estimate coming in at ($0.11) and the highest estimate coming in at ($0.10). Limoneira posted earnings per share of $0.44 in the same quarter last year, which would suggest a negative year over year growth rate of 125%. The company is scheduled to report its next quarterly earnings report on Monday, June 10th.
According to Zacks, analysts expect that Limoneira will report full year earnings of $0.64 per share for the current financial year, with EPS estimates ranging from $0.56 to $0.78. For the next year, analysts anticipate that the firm will report earnings of $1.17 per share, with EPS estimates ranging from $1.03 to $1.31. Zacks’ EPS calculations are an average based on a survey of research firms that that provide coverage for Limoneira.
Limoneira (NASDAQ:LMNR) last announced its quarterly earnings results on Tuesday, March 12th. The company reported ($0.11) earnings per share for the quarter, missing the consensus estimate of ($0.06) by ($0.05). Limoneira had a return on equity of 3.73% and a net margin of 4.91%. The business had revenue of $42.02 million during the quarter, compared to the consensus estimate of $44.74 million.
Several brokerages recently weighed in on LMNR. BidaskClub upgraded shares of Limoneira from a “strong sell” rating to a “sell” rating in a research report on Wednesday, May 8th. Zacks Investment Research cut shares of Limoneira from a “hold” rating to a “sell” rating in a research report on Wednesday, May 15th. ValuEngine upgraded shares of Limoneira from a “hold” rating to a “buy” rating in a research report on Wednesday, May 15th. Stephens cut shares of Limoneira from an “overweight” rating to an “equal weight” rating and reduced their price target for the stock from $25.00 to $18.00 in a research report on Tuesday, May 14th. Finally, Lake Street Capital set a $28.00 price target on shares of Limoneira and gave the stock a “buy” rating in a research report on Tuesday, May 14th. Two equities research analysts have rated the stock with a sell rating, one has given a hold rating and five have given a buy rating to the company. The company has a consensus rating of “Hold” and a consensus target price of $27.20.
LMNR traded up $0.05 during trading hours on Wednesday, hitting $19.04. The company’s stock had a trading volume of 53,560 shares, compared to its average volume of 67,199. Limoneira has a 12 month low of $18.07 and a 12 month high of $33.42. The stock has a market capitalization of $338.40 million, a PE ratio of 38.08, a P/E/G ratio of 2.26 and a beta of 0.96. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.28 and a current ratio of 1.38.
In other Limoneira news, Director John W.H. Merriman sold 1,811 shares of the business’s stock in a transaction on Tuesday, April 2nd. The shares were sold at an average price of $24.09, for a total transaction of $43,626.99. Following the transaction, the director now owns 2,011 shares in the company, valued at $48,444.99. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Robert M. Sawyer sold 1,250 shares of the business’s stock in a transaction on Thursday, March 14th. The shares were sold at an average price of $24.28, for a total transaction of $30,350.00. The disclosure for this sale can be found here. Insiders have sold 7,672 shares of company stock worth $179,285 in the last quarter. Company insiders own 4.50% of the company’s stock.
A number of hedge funds have recently bought and sold shares of LMNR. BNP Paribas Arbitrage SA boosted its stake in shares of Limoneira by 757.1% during the first quarter. BNP Paribas Arbitrage SA now owns 3,094 shares of the company’s stock valued at $73,000 after purchasing an additional 2,733 shares during the period. Metropolitan Life Insurance Co. NY boosted its stake in shares of Limoneira by 369.1% during the fourth quarter. Metropolitan Life Insurance Co. NY now owns 4,424 shares of the company’s stock valued at $86,000 after purchasing an additional 3,481 shares during the period. Oppenheimer Asset Management Inc. purchased a new stake in shares of Limoneira during the fourth quarter valued at $123,000. Citigroup Inc. boosted its stake in shares of Limoneira by 149.1% during the fourth quarter. Citigroup Inc. now owns 10,200 shares of the company’s stock valued at $199,000 after purchasing an additional 6,105 shares during the period. Finally, Stephens Inc. AR boosted its stake in shares of Limoneira by 2,988.0% during the fourth quarter. Stephens Inc. AR now owns 12,352 shares of the company’s stock valued at $241,000 after purchasing an additional 11,952 shares during the period. Institutional investors and hedge funds own 54.06% of the company’s stock.
Limoneira Company operates as an agribusiness and real estate development company in the United States and internationally. The company operates in six segments: Fresh Lemons, Lemon Packing, Avocados, Other Agribusiness, Rental Operations, and Real Estate Development. It grows, processes, packs, markets, and sells lemons.
Further Reading: What is the Rule of 72?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Limoneira Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Limoneira and related companies with MarketBeat.com's FREE daily email newsletter.